Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease - Wikidata - wikimedia - TriplyDB

Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease

Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease

http://www.wikidata.org/entity/Q35764189

about

Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease Role of CD8+ and CD4+ T lymphocytes in jejunal mucosal injury during murine giardiasis.Endometrial regenerative cells as a novel cell therapy attenuate experimental colitis in mice.Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis.Appendix is a priming site in the development of ulcerative colitis.Increased expression of IL-16 in inflammatory bowel disease Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease.Layers of mutualism with commensal bacteria protect us from intestinal inflammation.Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells.Therapeutic efficacy of a mutant of keratinocyte growth factor-2 on trinitrobenzene sulfonic acid-induced rat model of Crohn's disease.Phenotypic characterization of canine intestinal intraepithelial lymphocytes in dogs with inflammatory bowel disease RAG2-/- gamma(c)-/- mice transplanted with CD34+ cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus Enrichment of Circulating and Mucosal Cytotoxic CD8+ T Cells Is Associated with Postoperative Endoscopic Recurrence in Patients with Crohn's Disease STAT3 in epithelial cells regulates inflammation and tumor progression to malignant state in colon.Alterations of pulmonary function in patients with inflammatory bowel diseases.Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers.Intestinal inflammation and colorectal cancer: a double-edged sword?The dual role of inflammation in colon carcinogenesis Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis.Mesenchymal Stromal Cells Mitigate Experimental Colitis via Insulin-like Growth Factor Binding Protein 7-mediated Immunosuppression Anti-NKG2D mAb: A New Treatment for Crohn's Disease?Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase.Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.S1P Lyase Regulation of Thymic Egress and Oncogenic Inflammatory Signaling.Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases.Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease.

P2860

Q33762994-33E40422-8B36-4B97-87FE-EB60DD68DACA Q34146215-478FA2DF-AFA3-414E-810F-053CD446C61B Q34728538-AD75A279-20C7-4A96-AD84-101B256519C6 Q35381299-3E366A08-B138-428C-BBA9-DF3E46E14D6E Q35435811-8A76B925-C914-4082-A82C-D44301A931AB Q35565705-3B9622B9-FB31-4C10-B938-196A1680BEF2 Q35609191-C06154ED-D84A-46E5-98C1-ECE337E9CD2A Q36366156-3023F86E-144C-4FE8-9846-27D9528C05D4 Q36375570-9F7ED491-E0F3-45E3-B2E6-1A79C3BE8528 Q36841153-B0042422-EF77-49DD-8805-970267B3E25A Q36975560-FBFC380D-B48C-4FDF-AE48-D8C0C4699481 Q36994667-F9A6B93F-9803-4A05-A56D-7D42BEDA23F0 Q37118466-2785B718-68DF-4B58-B2D5-EC940107D3BA Q37162367-9FD58BE2-6DC3-4B45-974E-AE10C6E2ADBA Q37350565-FC812F96-899B-4924-88CA-C5F1E35A799F Q37620568-71451559-AC87-405F-932E-46FBB4B53775 Q37930988-ED240E6A-7C2F-42F7-B481-82802AFE72F5 Q38056490-55A4B72B-1CF8-4D60-9F29-C3E4967327F9 Q40519456-FDF315A0-3589-477F-B853-4ED0D9386DBC Q41653934-21E81DEE-40E0-4CE3-BA4B-BC251F662F65 Q41660377-DEF57250-5EA5-4074-AE27-A9AE6DBFBF22 Q43075788-BDE1AEE9-29AE-4CB4-AD81-EC982EA88291 Q43617341-0D3236EF-454F-45E5-8004-C820D84A88D6 Q48247517-252DF32F-FF6D-4B08-9C8A-69D176CA7E18 Q51700457-04DCDC2F-8E52-4851-A8C3-58A41EB4C729 Q52618987-A1CBCFE2-3BAF-4B6D-B992-27677D856BD5

P2860

Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease

http://www.wikidata.org/entity/Q35764189

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Activated CD4+ and CD8+ cytoto ...... ive inflammatory bowel disease

@ast

Activated CD4+ and CD8+ cytoto ...... ive inflammatory bowel disease

@en

type

label

Activated CD4+ and CD8+ cytoto ...... ive inflammatory bowel disease

@ast

Activated CD4+ and CD8+ cytoto ...... ive inflammatory bowel disease

@en

prefLabel

Activated CD4+ and CD8+ cytoto ...... ive inflammatory bowel disease

@ast

Activated CD4+ and CD8+ cytoto ...... ive inflammatory bowel disease

@en

P1433

Q35764189-82F72ADB-86D8-43F6-A665-3910DBB5E60C

P1476

Q35764189-EECA30DD-094E-46A6-AD19-41CB00449C85

P2093

Q35764189-2A19E226-4AFD-4F03-B28E-489EB1609B04

Q35764189-48224790-B8F9-4A3A-9F1D-0E60DA5276E5

Q35764189-923462E5-643F-45A9-8E4D-5D079915E657

Q35764189-93FD16BB-621B-45C2-B3E7-FB37462CD6C0

Q35764189-9EA7F7DE-9DA7-4759-AD58-2AFAC22091B6

Q35764189-B062F927-272C-4EA2-89E1-C859FAF9DFF7

Q35764189-F1735EEE-D857-444A-B842-65E6C310E202

P2860

Q35764189-033CBF43-DAE6-45DA-9380-B1F89B17CE91

Q35764189-0B5AB396-EE0C-49B5-A900-BA4D33579C14

Q35764189-30E2C13E-1379-4768-9C6F-08ED04B4C005

Q35764189-37C867B1-F939-4834-AA2C-6D1F44C130A4

Q35764189-38D35417-F3BD-4097-8491-9EBD99C2B77E

Q35764189-4274FA68-928E-435E-A881-85590370EE66

Q35764189-4439AFB6-8014-4C35-A172-6B9A3F862915

Q35764189-69A7ACAB-E88A-4274-BFCD-6F59E1BA20F7

Q35764189-7041B7D1-0DE7-4870-86BA-D3DD16F1CDB5

Q35764189-72EA01E1-B7EB-4D82-A75B-9C3CBF2AD374

P304

Q35764189-31FE52FD-C6F4-4382-BFC1-3CFCCBC5BE9E

P31

Q35764189-3FF13A54-C017-4DBE-B166-693B2C96A25A

P407

Q35764189-9F3CFB04-6CA8-43C6-B9BF-0A22B5837D9A

P433

Q35764189-97A714A5-22D4-4EA9-A1E8-22421878EE28

P478

Q35764189-E097064F-B855-4A8A-97DA-8898C332D8C3

P50

Q35764189-064B8423-1CE5-46DD-980E-724957894F98

P577

Q35764189-3EC43D68-690E-406F-9A9E-7498474CF6BC

P698

Q35764189-C9BEC71C-5AA9-4913-9C7F-7A272A5EAE0D

P921

Q35764189-7FFAEBEB-BC0F-4A4A-986F-A4FFAE6D659D

P932

Q35764189-777635C7-F600-4CD0-A50F-91AB39254B4B

P1433

The American Journal of Pathology

P1476

Activated CD4+ and CD8+ cytoto ...... ive inflammatory bowel disease

@en

P2093

Corazza N

http://www.w3.org/2001/XMLSchema#string

Kappeler A

http://www.w3.org/2001/XMLSchema#string

Lory J

http://www.w3.org/2001/XMLSchema#string

Mazzucchelli L

http://www.w3.org/2001/XMLSchema#string

Mueller C

http://www.w3.org/2001/XMLSchema#string

Müller S

http://www.w3.org/2001/XMLSchema#string

Z'graggen K

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and chromosomal assignment of a human cDNA encoding a T cell- and natural killer cell-specific trypsin-like serine protease

Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8

Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity

Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis

Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

Interleukin-10-deficient mice develop chronic enterocolitis

Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.

Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry.

Structure and function of human perforin.

P304

261-268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

152

http://www.w3.org/2001/XMLSchema#string

P50

Gillian Griffiths

P577

1998-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9422543

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

1858122

http://www.w3.org/2001/XMLSchema#string